申请人:Ciba Geigy Corporation
公开号:US04600719A1
公开(公告)日:1986-07-15
Compounds of the class of (2-benzofuranyl)-1,2,3,6-tetrahydropyridines and (2-benzofuranyl)-piperidines which at the ring nitrogen atom are unsubstituted or substituted by a substituent of the class of certain aliphatic, cycloaliphatic and araliphatic radicals, and their pharmaceutically acceptable acid addition salts have valuable pharmacological properties. In particular, they inhibit monoamine oxidase and antagonise the action of tetrabenazine. They are useful as active ingredients for therapeutic compositions for the treatment of mental depression. Specific embodiments are 4-(2-benzofuranyl)-piperidine, 2-(5,6-dimethyl-2-benzofuranyl)-piperidine and their hydrochlorides.
(2-苯并呋喃基)-1,2,3,6-四氢吡啶和(2-苯并呋喃基)-哌啶的化合物,其环氮原子未被取代或被取代为特定的脂肪族、环脂族和芳基脂肪族基团,以及它们的药学上可接受的酸盐具有有价值的药理学特性。特别是,它们能够抑制单胺氧化酶并拮抗替巴肼的作用。它们可用作治疗抑郁症的治疗组合物的活性成分。具体实施例包括4-(2-苯并呋喃基)-哌啶、2-(5,6-二甲基-2-苯并呋喃基)-哌啶及其盐酸盐。